Letter of Revocation: DPP® COVID-19 IgM/IgG System – Chembio Diagnostic Systems, Inc. | NLM

Disaster Information Management Research Center | NLM

Letter of Revocation: DPP® COVID-19 IgM/IgG System – Chembio Diagnostic Systems, Inc.

06/16/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/16/2020. This three-page letter, issued on June 16, 2020, is notification of the revocation of the Emergency Use Authorization for the DPP® COVID-19 IgM/IgG System, which received an Emergency Use Authorization from the Food and Drug Administration on April 14, 2020. (PDF)